NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
ACC Ltd. reported beat on volume/revenue/Ebitda, however Ebitda/tonne and adjusted profit after tax were in-line; realisation/tn was below estimates. Revenue grew by 12.9% YoY to Rs 54.1 billion (+10.1% QoQ), led by volume growth of +23.5% YoY to 10.4 milliot (+17.3% QoQ) partially offset by -7.4% YoY in realisation to Rs 4,874 (+6.0% QoQ).
Ebitda/adjusted profit after tax were up by 78.6%/51.6% YoY to Rs 8.4 billion/Rs 4.6 billion, led by better operating performance.
We expect revenue/Ebitda/adjusted profit after tax compound annual growth rate of 5.1%/17.0%/15.8% over FY24- 26E, led by +6.2%/+6.4% volume growth and -2.5%/+1.0% cement realisation growth in FY25E/FY26E.
ACC, in our view, will also be a key beneficiary of group synergies in cost reduction and thereby result in aiding overall profitability.
We maintain our Ebitda estimates for FY25E, but increase estimates by 6.5% for FY26E post factoring lower opex. Maintain ‘Accumulate’ rating on the stock with revised target price of Rs 2,765 based on 11 times consolidated FY26E EV/Ebitda.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Why Is Apollo Hospitals Stock Poised For Re-Rating? Read PL Capital Report


'Buy' Inox Wind Shares For Potential Upside Of 35% Says Axis Securities


Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains 'Hold' Rating — Check Target Price


'Buy' ACC Shares Maintains Systematix Post Q1 Results, Revises Target Price — Here's Why
